Clinical trials
Phase 2 Macular Degeneration trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AnewPharma | 1 |
| California Retina Consultants | 1 |
| Control Delivery Systems | 1 |
| Federal University of São Paulo | 1 |
| Opto Eletronica S.A. | 1 |
| Oraya Therapeutics, Inc. | 1 |
| Othera Pharmaceuticals | 1 |
| Rafic Hariri University Hospital | 1 |
| Theratocular Biotek Co. | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 11 |
| Wet Macular Degeneration | 2 |
| Choroidal Neovascularization | 1 |
| Diabetic Retinopathy | 1 |
| Eye Diseases | 1 |
| Geographic Atrophy | 1 |
| Glaucoma, Neovascular | 1 |
| Macular Edema | 1 |
| Neovascularization, Pathologic | 1 |
| Pterygium | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.